BYON8, a Kenyan healthtech business, has acquired $1.5 million in seed funding backed by Danish early-stage investor People Ventures.
T&W Holding, a new investor, and Jellyfish also took part.
Josef Murad and Matias Murad founded BYON8 in 2015.
Its vision was to digitize the healthcare system, creating a platform where doctors could be easily reached by patients.
The startup strengthens healthcare processes by leveraging mathematical algorithms and medical AI to convert patient data into calculated diagnosis propositions, making it accessible to everyone, regardless of financial status.
BYON8 consists of two major services: a free symptom checker that allows users to enter their symptoms and determine what is causing them, and a paid symptom checker that assists users in determining what is causing their symptoms.
Booking appointments with licensed doctors and communicating with them via video or built-in chat.
“Having People Ventures lead our Seed round is a fantastic endorsement of the work we’ve done thus far, as well as the company’s continuous development and momentum. Josef Murad, MD, CEO and Co-Founder of BYON8, says, “This funding will be used to fuel our growth in emerging areas, starting with Kenya.”
With 4 billion people living in the globe without access to basic healthcare, a device like BYON8 has a huge chance to increase healthcare access, Murad added.
Claus Zibrandtsen, Managing Work at People Venture, said, “We are tremendously delighted to partner with BYON8 and support them on their vision to make healthcare a right, not a privilege.”
The platform asks the user a series of questions based on their medical history and present symptoms and then gives them feedback and guidance.
BYON8 can also keep track of users’ health information, lab reports, health care visits, and other important details.